Sort
16,300 grants matching “fatty liver disease”
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
$0Randy Scott Rector · Harry S. Truman Memorial Va Hospital · IK2 · FY2012 · VA
Role of Intestinal Bile Acid Signaling in Liver Diseases
$0Grace L Guo · Va New Jersey Health Care System · I01 · FY2023 · VA
Is HIV-associated lipodystrophy a risk factor for cirrhosis of the liver?
$0George Ioannou · Va Puget Sound Healthcare System · I01 · FY2013 · VA
CD47 as a therapeutic target for obesity
$0Shuxia Wang · Va Medical Center - Lexington, Ky · I01 · FY2019 · VA
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
$0Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System · I01 · FY2019 · VA
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease
$0Huiping Rose Zhou · Va Veterans Administration Hospital · I01 · FY2019 · VA
PREVALENCE AND PREDICTORS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN VETERANS
$0Hashem B El-Serag · Michael E Debakey Va Medical Center · I01 · FY2019 · VA
Functional characters of non-coding RNAs in alcoholic liver injury
$0Fanyin Meng · Rlr Va Medical Center · I01 · FY2020 · VA
Early Detection of HCC Among Veterans With Liver Cirrhosis
$0Srikanta Dash · Southeast Louisiana Veterans Health Care · I01 · FY2020 · VA
Circadian Clock Regulation of Alcoholic Liver Disease
$0Li Wang · Va Connecticut Healthcare System · I01 · FY2019 · VA
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
$0Gianfranco D. Alpini · Rlr Va Medical Center · I01 · FY2020 · VA
Molecular mechanisms of Insulin resistance under chronic stress
$0Yang K Xiang · Va Northern California Health Care Sys · I01 · FY2021 · VA
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)
$0George Ioannou · Va Puget Sound Healthcare System · I01 · FY2023 · VA
Study the role of oxysterol sulfates in NAFLD development
$0Shunlin Ren · Va Veterans Administration Hospital · I01 · FY2022 · VA
Molecular Mechanisms of Mitigation of Insulin Induction of SREBP-1c by N-3 PUFA
$0Marshall B Elam · Memphis Va Medical Center · I01 · FY2012 · VA
Actions of Calcium Regulating Hormones on the Gut
$0University Of Texas Medical Br Galveston · P01 · FY2002 · DK
Regulation of Innate Immunity and Inflammation Through Nuclear Reprogramming
$0Jack J Hawiger · Veterans Health Administration · I01 · FY2019 · VA
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
$0Roger H. Unger · Va North Texas Health Care System · I01 · FY2019 · VA
Central Mechanisms Regulating Macronutrient Intake
$0Matthew Joseph Potthoff · Iowa City Va Medical Center · I01 · FY2020 · VA
BLR&D Research Career Scientist Award Application
$0Nicholas J Webster · Va San Diego Healthcare System · IK6 · FY2020 · VA
Paracrine Mechanisms of Prostate Cancer Metastatic Progression
$0Neil A Bhowmick · Va Greater Los Angeles Healthcare System · I01 · FY2019 · VA
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease
$0Anne S Henkel · Jesse Brown Va Medical Center · I01 · FY2019 · VA
The Role of Relaxin Signaling in Adipose Tissue Fibrosis and Function
$0Robert G Bennett · Omaha Va Medical Center · I01 · FY2023 · VA
Dietary Fat and Alcoholic Liver Disease
$0Craig J McClain · Louisville Va Medical Medical Center · I01 · FY2020 · VA
Mechanisms of glucagon-like peptide 1 (GLP-1) in fatty liver disease
$0Frank A. Anania · Veterans Health Administration · I01 · FY2013 · VA